CV Sciences, Inc. Loss Form

Company: CV Sciences, Inc.




Lead Plaintiff Deadline: October 23, 2018

Case Alerts

Every year, thousands of shareholders miss deadlines to receive settlement funds. Make sure you don’t. Sign up for case alerts.

To receive more detailed alerts provide your information below.

Request Case Alerts

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit. No spam will be sent to your email.


(i) CV Sciences’ Patent for CVSI-007, the Company’s leading drug candidate, had been rejected by the USPTO; (ii) accordingly, CV Sciences had significantly overstated the commercial viability of CVSI-007; and (iii) as a result, CV Sciences’ public statements were materially false and misleading at all relevant times.